相关实验视频
Updated: Sep 12, 2025

07:32
Murine Fecal Isolation and Microbiota Transplantation
Published on: May 26, 2023
4.4K
通过肠道微生物组治疗心灵病的新机会
Yurui Lai1,2, Chenli Fang3, Yuang Jiang4
1Department of Cardiology, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, China.
Frontiers in cardiovascular medicine
|August 6, 2025
概括
心血管疾病 (CVD) 患者经常经历精神疾病,影响预后. 肠道微生物群失调和代谢物是关键的危险因素,这表明精神心脏病的新疗法目标.
科学领域:
- 综合医学是一个整体的医学.
- 微生物组研究的研究.
- 精神心脏病学心脏病学
背景情况:
- 心血管疾病 (CVD) 与抑郁症和焦虑症等精神疾病的并发症正在增加.
- 患有并发性心血管疾病和精神疾病的患者表现出较差的健康结果.
- 肠道微生物群失调和变化的代谢物概况被认为是心血管疾病和精神疾病的风险因素.
研究的目的:
- 审查将肠道微生物群及其代谢物与心脏病相关联的机制.
- 总结肠道微生物群干预措施在管理这些疾病中的治疗潜力.
- 为突出治疗心灵病的新研究方向.
主要方法:
- 关于肠道微生物群,代谢物,心血管疾病和精神疾病的研究的文献综述.
- 对连接肠道失调与心灵病理生理学的机制的分析.
- 对肠道微生物向治疗的证据评估.
主要成果:
- 肠道微生物群失调和特定代谢物变化是精神心脏病的重要危险因素.
- 这些微生物变化有助于心血管和精神疾病的病理生理学.
- 肠道微生物群干预表明作为治疗策略有前途.
结论:
- 肠道微生物群在精神心脏病的发展和进展中起着至关重要的作用.
- 针对肠道微生物群为患有并发性心血管疾病和精神疾病的患者提供了一种新的治疗途径.
- 进一步研究基于微生物群的干预措施是有必要的,以改善患者的预后.
相关概念视频
Psychoneuroimmunology: Cardiovascular Disease
78
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
78
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
271
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
271
What is Monogastric Digestion?
72.5K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
72.5K
Microorganisms in Medicine and Therapeutics
337
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
337
Drugs for Treatment of Diarrhea-Predominant IBS
294
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
294
Drugs for Treatment of Ulcerative Colitis in IBD
238
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
238

